MGA

Across TCGA pan-cancer cohorts, MGA mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MGA data layer compared with 24 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher MGA mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated MGA expression acts as an unfavorable survival marker, although some lineages such as LSCC and UCEC show a favorable association.

LSCC, UCEC, and LUAD are the cancer types where MGA mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Tertile	II,III,IV	0.887	0.415	.001	41	view →
UCEC	OS	Median	All	0.983	0.855	.017	6	view →
LUAD	DFS	Median	II,III,IV	0.753	0.270	.037	5	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MGA–LSCC (DFS)

Open the LSCC breakdown →